InspireMD director Paul Stuka purchased 75,626 shares of the company's common stock through open-market transactions on May 8 and May 11, 2026. These ...
InspireMD, Inc. director Gary S. Roubin recently made an open-market purchase of 90,000 shares of common stock at a weighted average price of $1.18 pe...
Neutral
This article provides only the title for information about the number of shareholders of InspireMD Inc. (II2) on GETTEX. The content is primarily navi...
Neutral
InspireMD (NSPR) has issued a voluntary U.S. recall for its CGuard Prime 135 cm carotid stent delivery system due to performance issues, leading to th...